Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 18310311.
- Also identified by DOI 10.1136/bjo.2007.123190 and PMC identifier 5993190.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether four expression-related cytokine polymorphisms are associated with age-related macular degeneration (AMD). DNA from 478 cases with AMD and 555 normal controls was genotyped for the pro-inflammatory IL1beta -511C/T, IL6 -174C/G, IL8 -251A/T and anti-inflammatory IL10 -1082G/A cytokine polymorphisms using the 5' nuclease TaqMan(R) assay for allelic discrimination. Associations with AMD were analysed using allelic frequencies. The -251A allele of the IL8 promoter gene polymorphism was more prevalent in AMD patients than controls (p = 0.037, OR = 1.21, 95% CI = 1.01 to 1.44). Adjusting for age, sex, body mass index (BMI), current smoking and past smoking status did not alter the AMD association significantly (corrected p value = 0.043, OR = 1.23, 95% CI = 1.0 to 1.50). The pro-inflammatory homozygous IL8 -251AA genotype is an important risk factor for AMD. This may have implications for future therapy with biological agents that could target this cytokine.
Medical subject headings
- Genetic Predisposition to Disease
- Interleukin-8
- Macular Degeneration
- Polymorphism, Single Nucleotide